Target identification leading to novel, druggable targets for therapeutic intervention remains a top priority for the pharma/biotech industry when it .. Read more comes to building a robust drug discovery pipeline. It also remains a formidable challenge and companies continue to invest a lot of resources in finding and validating good drug targets. Where are the challenges when it comes to identifying and validating targets? What tools and strategies are being used and how well are they working? What’s being done once targets are validated that will lead to better and safer therapies? Cambridge Healthtech Institute’s inaugural conference on Target Identification Strategies will bring together leading experts to highlight the key developments in this field. This conference will help attendees network with experts and peers from around the world to share ideas and hear about new approaches for target identification that they can implement in their labs..
- Share your Experience
More Events From The Organizer
- Biotherapeutics Analytical Sum..29 Sep 2020Online